For adults with moderate to severe ulcerative colitis (UC) in whom TNF blockers did not work well

Results

RINVOQ

The proof is in the clinical studies

7 out of 10

Once-daily RINVOQ helped people living with UC get:

Rapid relief from UC symptoms* in as early as 2 weeks

*Based on the frequency of bowel movements and the amount of bloody stools.

No bowel urgency and no abdominal pain in 8 weeks

Steroid-free remission

Visible colon lining repair

More RINVOQ results
that won't back down

RAPID SYMPTOM RELIEF

In Study 1 and Study 2 combined, 62% of people taking RINVOQ 45 mg (n=660) reported less frequent bowel movements and bloody stools compared to 27% of people taking placebo (n=328) at Week 2

SYMPTOM RELIEF

In Study 2, 75% of people taking RINVOQ 45 mg (n=341) experienced symptom relief compared to 25% of people taking placebo (n=174) at Week 8

SYMPTOM RELIEF

At week 8, ~73% of people taking RINVOQ 45 mg (n=319) in study 1 and 75% of people taking RINVOQ 45 mg (n=341) in study 2 experienced symptom relief, compared to 27% of people taking placebo in study 1 (n=154) and 25% of people taking placebo in study 2 (n=174)

*Based on the frequency of bowel movements, the amount of bloody stools, and the visible appearance of the colon lining.

VISIBLE COLON
LINING REPAIR

In Study 2, 44% of people taking RINVOQ 45 mg (n=341) experienced a visible improvement of the colon lining compared to 8% of people taking placebo (n=174) at Week 8

VISIBLE COLON
LINING REPAIR

At week 8, 36% of people taking RINVOQ 45 mg (n=319) in study 1 and 44% of people taking RINVOQ 45 mg (n=341) in study 2 experienced a visible improvement of the colon lining, compared to 7% of people taking placebo in study 1 (n=154) and 8% of people taking placebo in study 2 (n=174)

LASTING
STEROID-FREE REMISSION

In study 3, of those who achieved remission at week 8, 68% of people taking RINVOQ 30 mg (n=58) and 57% of people taking RINVOQ 15 mg (n=47) achieved steroid-free remission at one year, compared to 22% of people taking placebo (n=54)

VISIBLE COLON
LINING REPAIR

In Study 3, 62% of people taking RINVOQ 30 mg (n=154) and 49% of people taking RINVOQ 15 mg (n=148) experienced a visible improvement of the colon lining at one year, compared to 15% of people taking placebo (n=149)

REMISSION AT 1 YEAR:

42% of people taking RINVOQ 15mg and 52% of people taking RINVOQ 30mg achieved remission, compared to 12% of people taking placebo

Make once-daily RINVOQ part of your routine. Get the facts about Taking RINVOQ for UC >


Take charge: More topics for you

Speak up—and often

You are your best advocate. Ask your
gastroenterologist about RINVOQ and
how it can help you achieve your
long-term treatment goals.

Explore appointment tips and tools > 

Understanding potential side effects

Before taking RINVOQ, it’s important to weigh the potential benefits and risks with your gastroenterologist.

Learn more about side effects >